- Home
- KRMD vs ARTV Comparison
KRMD vs ARTV Comparison
Compare KRMD & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- ARTV
- Stock Information
- Founded
- KRMD 1980
- ARTV 2019
- Country
- KRMD United States
- ARTV United States
- Employees
- KRMD N/A
- ARTV N/A
- Industry
- KRMD Medical/Dental Instruments
- ARTV
- Sector
- KRMD Health Care
- ARTV
- Exchange
- KRMD Nasdaq
- ARTV NYSE
- Market Cap
- KRMD 126.9M
- ARTV 61.9M
- IPO Year
- KRMD N/A
- ARTV 2024
- Fundamental
- Price
- KRMD $3.29
- ARTV $2.18
- Analyst Decision
- KRMD Strong Buy
- ARTV Strong Buy
- Analyst Count
- KRMD 4
- ARTV 7
- Target Price
- KRMD $4.63
- ARTV $20.00
- AVG Volume (30 Days)
- KRMD 118.8K
- ARTV 213.6K
- Earning Date
- KRMD 05-07-2025
- ARTV 05-08-2025
- Dividend Yield
- KRMD N/A
- ARTV N/A
- EPS Growth
- KRMD N/A
- ARTV N/A
- EPS
- KRMD N/A
- ARTV N/A
- Revenue
- KRMD $35,083,740.00
- ARTV N/A
- Revenue This Year
- KRMD $16.50
- ARTV N/A
- Revenue Next Year
- KRMD $15.47
- ARTV N/A
- P/E Ratio
- KRMD N/A
- ARTV N/A
- Revenue Growth
- KRMD 19.65
- ARTV N/A
- 52 Week Low
- KRMD $1.86
- ARTV $1.78
- 52 Week High
- KRMD $5.05
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- KRMD 71.25
- ARTV N/A
- Support Level
- KRMD $2.51
- ARTV N/A
- Resistance Level
- KRMD $2.86
- ARTV N/A
- Average True Range (ATR)
- KRMD 0.19
- ARTV 0.00
- MACD
- KRMD 0.09
- ARTV 0.00
- Stochastic Oscillator
- KRMD 96.12
- ARTV 0.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).